Healthcare professionals are not immune to the nationwide epidemic of controlled substance addiction, and they often have ready access to large quantities of controlled substances. As a result, roughly 10% of all healthcare workers will divert drugs in their careers. While the opportunity for diversion in healthcare facilities has always been present, the DEA, state regulators and law enforcement have traditionally focused their enforcement efforts elsewhere. Recently, however, hospitals have drawn greater regulatory scrutiny and publicity with regard to their role in drug diversion. There has been an uptick in DEA enforcement actions, with a number of hospitals entering into settlement agreements with the DEA in the past 12 months for having lax controls that led to employee drug diversion and, in some cases, overdose and death. This Roundtable will focus on important developments and practical tips for ensuring compliance and effectiveness with regard to controlled substances in the hospital context, including:
- Recent DEA activity demonstrating elevated concern with regard to controlled substance security, oversight and management in the hospital context;
- Unique risks present in the hospital setting, especially with regard to healthcare workers;
- Legal framework and key issues hospitals need to consider in evaluating their compliance programs and monitoring tools; and
- Best practices with regard to a hospital’s controlled substance compliance program and diversion prevention.
Tuesday, January 15, 2019
1:00 P.M. – 2:00 P.M. ET
CLE credit will be applied for in CA, GA, IL, NY, TX and, if needed, NC and VA. Attendees will receive a Uniform Certificate of Attendance via email approximately 30 days after the program to seek CLE credit in other jurisdictions. New York lawyers: This program is considered transitional and non-transitional in content. The interactive webinar format is synchronous and approved for all lawyers. King & Spalding LLP / 1180 Peachtree Street, Atlanta, GA 30309 | CA Provider # 10947.